Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
05/2012
05/10/2012US20120115127 Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
05/10/2012US20120114793 Method of Preparing A Heat-Treated Product
05/10/2012US20120114700 Lat adapter molecule for enhanced t-cell signaling and method of use
05/10/2012US20120114694 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
05/10/2012US20120114687 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
05/10/2012US20120114683 Nucleic Acid Encoding TGEV and PRRSV Sequences for Improved Expression of PRRSV Sequences
05/10/2012US20120114679 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/10/2012US20120114667 TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF
05/10/2012US20120114662 Human monoclonal antibodies against bacillus anthracis protective antigen
05/10/2012US20120114657 Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of Serotype IATS 01 of Pseudomonas Aeruginosa
05/10/2012US20120114655 Xylan utilization regulon for efficient bioprocessing of hemicellulose and uses thereof
05/10/2012US20120114603 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities
05/10/2012US20120114602 Process for the synthesis of conjugates of glycosaminoglycanes (gag) with biologically active molecules, polymeric conjugates and relative uses thereof
05/10/2012US20120114558 Aptamer-mediated drug release
05/10/2012CA2816584A1 Compositions of a peptide-based system for cell-specific targeting
05/10/2012CA2814414A1 Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
05/09/2012EP2450441A2 Heparan sulfate glycosaminoglycan lyase and uses thereof
05/09/2012EP2449114A1 Novel lipid formulations for delivery of therapeutic agents to solid tumors
05/09/2012EP2449104A2 Chimeric primers with hairpin conformations and methods of using same
05/09/2012EP2448955A1 Acyl-acp thioesterase genes and uses therefor
05/09/2012EP2448954A1 Synthesis of cyclic diguanosine monophosphate and thiophosphate analogs thereof
05/09/2012EP2448952A2 Novel guanosine-rich modified oligonucleotides and antiproliferative activity thereof
05/09/2012EP2213292B1 Double-stranded oligonucleotides
05/09/2012EP1766021B1 Polynucleotides for the detection of escherichia coli o157:h7 and escherichia coli o157:nm verotoxin producers
05/09/2012EP1750771B1 Pancreatic islet microrna and methods for inhibiting same
05/09/2012EP1737966B1 Cancer specific promoters
05/09/2012EP1709200B1 Double stranded linear nucleic acid probe and uses thereof
05/09/2012EP1660686B1 Hpv cd8+ t-cell epitopes
05/09/2012EP1501842B1 Solid supports functionalised by phosphorus dendrimers, method for preparing same and uses thereof
05/09/2012EP1409506B1 Methods and compositions for rnai mediated inhibition of gene expression in mammals
05/09/2012CN1836045B Novel plant promoters for use in early seed development
05/09/2012CN1620513B High throughput assay system
05/09/2012CN1616676B Probe set
05/09/2012CN102448977A Multiplexed sites for polymer synthesis
05/09/2012CN102448288A Transgenic rice event17314 and methods of use thereof
05/09/2012CN102443030A Photocleavable labeled nucleotides and nucleosides and labeled nucleotides and nucleosides and methods for their use in DNA sequencing
05/09/2012CN101649317B Method for quickly extracting and preserving silica gel membrane type DNA
05/09/2012CN101268188B Novel artificial base pair and use thereof
05/09/2012CN101260148B Hybrid and tandem expression of neisserial proteins
05/08/2012US8173872 Bacillus thuringiensis insecticidal proteins
05/08/2012US8173870 Polynucleotide sequence encoding polypeptide; expression vectors; extraction of soybean oil; transgenic plants; genetic engineering, transformation
05/08/2012US8173869 Plants expressing environmental stress tolerances having petunia CBF genes therein
05/08/2012US8173863 Sucrose biosensors and methods of using the same
05/08/2012US8173859 Epilepsy model animal
05/08/2012US8173798 Vaccine
05/08/2012US8173796 Oligonucleotide compositions and methods for treating disease including inflammatory conditions
05/08/2012US8173795 Methods and compositions for identifying and characterizing hepatitis C
05/08/2012US8173793 Nucleic acids encoding modulators of body weight
05/08/2012US8173792 Method for regulating protein function in cells using synthetic small molecules
05/08/2012US8173791 Luciferases and methods for making and using the same
05/08/2012US8173789 Peptide having ability to activate cancer-related gene
05/08/2012US8173788 Peptide having ability to activate cancer-related gene
05/08/2012US8173786 Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
05/08/2012US8173782 Fusion protein comprising growth hormone and growth hormone receptor
05/08/2012US8173776 Recombinant gelatins
05/08/2012US8173617 RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
05/08/2012US8173616 RNA-induced translational silencing and cellular apoptosis
05/08/2012US8173615 TRPM-2 antisense therapy
05/08/2012US8173614 Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof
05/08/2012US8173613 Modulation of mesenchymal and metastatic cell growth
05/08/2012US8173612 Chemotherapy involving antisense oligonucleotides for preventing and/or treating pulmonary fibrosis
05/08/2012US8173603 Methods of using BTL-II proteins
05/08/2012US8173445 DNA intercalating agents
05/08/2012US8173428 LNA oligonucleotides and the treatment of cancer
05/08/2012US8173424 Internalizing ErbB2 antibodies
05/08/2012US8173423 Diagnosis and treatment of T-cell acute lymphoblastic leukemia
05/08/2012US8173422 Method for improving protein production
05/08/2012US8173410 Isoprene synthase variants for improved microbial production of isoprene
05/08/2012US8173408 Recombinant carrier molecule for expression, delivery and purification of target polypeptides
05/08/2012US8173402 Modified yeasts and uses thereof, in particular for producing steroid derivatives
05/08/2012US8173396 Methods for reducing gluconoylation of proteins
05/08/2012US8173393 Expanding the eukaryotic genetic code
05/08/2012US8173363 Random transposon insertion in Staphylococcus aureus and use thereof to identify essential genes
05/08/2012US8173198 Deposition of metal oxides onto surfaces as an immobilization vehicle for carboxylated or phophated particles or polymers
05/08/2012US8173137 Polycistronic HIV vector constructs
05/08/2012US8173134 ECD carboxy-terminal deletion FGFR4 fusion proteins and methods of producing them
05/08/2012US8173122 Methods of treatment using antibodies to neutrokine-alpha
05/08/2012CA2623339C Virulence genes in the vgc2 cluster of salmonella
05/08/2012CA2520636C Variant humicola grisea cbh1.1
05/08/2012CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
05/08/2012CA2163211C Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
05/08/2012CA1341629C Hepatitis c diagnostics and vaccines
05/03/2012WO2012058266A1 Overexpression of plant mirnas for parasite control
05/03/2012WO2012058210A1 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)
05/03/2012WO2012057934A1 Immunogenic agents
05/03/2012WO2012056441A1 Compositions and methods for specific cleavage of exogenous rna in a cell
05/03/2012WO2012056440A1 COMPOSITIONS AND METHODS FOR ACTIVATING EXPRESSION BY A SPECIFIC ENDOGENOUS miRNA
05/03/2012WO2012018691A3 Novel fungal enzymes
05/03/2012WO2011163116A3 CHRONIC LYMPHOCYTIC LEUKEMIA MODELED IN MOUSE BY TARGETED miR-29 EXPRESSION
05/03/2012US20120110706 Modified bacillus thuringiensis cry21 proteins for nematode control
05/03/2012US20120110700 Plants with altered root architecture, related constructs and methods involving genes encoding leucine rich repeat kinase (llrk) polypeptides and homologs thereof
05/03/2012US20120110688 Aad-12 event 1606 and related transgenic soybean lines
05/03/2012US20120108804 Compositions and methods for preparing short rna molecules and other nucleic acids
05/03/2012US20120108803 Sirna conjugate and preparation method thereof
05/03/2012US20120108799 Modifications for Antisense Compounds
05/03/2012US20120108787 Immobilization Particles for Removal of Microorganisms and/or Chemicals
05/03/2012US20120108662 Compositions and methods for treating skin disorders
05/03/2012US20120108653 Oligomers
05/03/2012US20120108652 Oligomers
05/03/2012US20120108651 Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 899